Evidence map›Paper›PMID 18272180›Full record

ArticleJournal of molecular biology2008

Order-disorder-order transitions mediate the activation of cholera toxin.

Ravi S Ampapathi, Andrea L Creath, Dianne I Lou, John W Craft, Steven R Blanke, Glen B Legge

Abstract read
In one paragraph

Article in Journal of molecular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Carbohydrate inhibitors of cholera toxin.Beilstein journal of organic chemistry · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ravi S AmpapathiDepartment of Biology and Biochemistry, University of Houston, Houston, TX, USA.
Andrea L Creath
Dianne I Lou
John W Craft
Steven R Blanke
Glen B Legge
University of Houston · USUniversity of Illinois Urbana-Champaign · US

Funding

Training in Pharmacoinformatics(RMI)R90DK071505 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI STANCEL, GEORGE M. · 2004 to 2008
$1.4M
NIDDK NIH HHS R90 DK071505
6 · The paper itself

Abstract

Cholera toxin (CT) holotoxin must be activated to intoxicate host cells. This process requires the intracellular dissociation of the enzymatic CTA1 domain from the holotoxin components CTA2 and B5, followed by subsequent interaction with the host factor ADP ribosylation factor 6 (ARF6)-GTP. We report the first NMR-based solution structural data for the CT enzymatic domain (CTA1). We show that this free enzymatic domain partially unfolds at the C-terminus and binds its protein partners at both the beginning and the end of this activation process. Deviations from random coil chemical shifts (Delta delta(coil)) indicate helix formation in the activation loop, which is essential to open the toxin's active site and occurs prior to its association with human protein ARF6. We performed NMR titrations of both free CTA1 and an active CTA1:ARF6-GTP complex with NAD(+), which revealed that the formation of the complex does not significantly enhance NAD(+) binding. Partial unfolding of CTA1 is further illustrated by using 4,4'-bis(1-anilinonaphthalene 8-sulfonate) fluorescence as an indicator of the exposed hydrophobic character of the free enzyme, which is substantially reduced when bound to ARF6-GTP. We propose that the primary role of ARF6's allostery is to induce refolding of the C-terminus of CTA1. Thus, as a folded globular toxin complex, CTA1 escapes the chaperone and proteasomal components of the endoplasmic reticulum associated degradation pathway in the cytosol and then proceeds to ADP ribosylate its target G(s)alpha, triggering the downstream events associated with the pathophysiology of cholera.

Indexed as

ADP-Ribosylation Factor 6ADP-Ribosylation FactorsAllosteric RegulationAnilino NaphthalenesulfonatesBinding SitesCholera ToxinFluorescent DyesGuanosine TriphosphateHydrophobic and Hydrophilic InteractionsModels, MolecularNADNuclear Magnetic Resonance, BiomolecularProtein ConformationProtein FoldingRecombinant Proteins5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)ADP-Ribosylation Factor 6ADP-Ribosylation FactorsAnilino NaphthalenesulfonatesARF6 protein, humanCholera ToxinFluorescent DyesGuanosine TriphosphateNADRecombinant Proteins

Identifiers

PMID18272180
PMCPMC2441595
OpenAlexW2047059517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.